Cited by 616Amyotrophic Lateral Sclerosis ResearchHereditary Neurological DisordersAlzheimer's disease research and treatments

The DOI matches its Crossref record; 201 of the 202 references it cites were found in a registry or an index.

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

Open access

Ferraiuolo, Laura, Kirby, Janine, Grierson, Andrew J., Sendtner, Michael, Shaw, Pamela J.·2011·Nature Reviews Neurology

DOI 10.1038/nrneurol.2011.152

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a genetically diverse disease. At least 15 ALS-associated gene loci have so far been identified, and the causative gene is known in approximately 30% of familial ALS cases. Less is known about the factors underlying the sporadic form of the disease. The molecular mechanisms of motor neuron degeneration are best understood in the subtype of disease caused by mutations in superoxide dismutase 1, with a current consensus that motor neuron injury is caused by a complex interplay between multiple pathogenic processes. A key recent finding is that mutated TAR DNA-binding protein 43 is a major constituent of the ubiquitinated protein inclusions in ALS, providing a possible link between the genetic mutation and the cellular pathology. New insights have also indicated the importance of dysregulated glial cell-motor neuron crosstalk, and have highlighted the vulnerability of the distal axonal compartment early in the disease course. In addition, recent studies have suggested that disordered RNA processing is likely to represent a major contributing factor to motor neuron disease. Ongoing research on the cellular pathways highlighted in this Review is predicted to open the door to new therapeutic interventions to slow disease progression in ALS.

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2011.152

Cites

201 of 201 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 retracted

RETRACTED: Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
Retracted
Induction of the Unfolded Protein Response in Familial Amyotrophic Lateral Sclerosis and Association of Protein-disulfide Isomerase with Superoxide Dismutase 1
Atkin, J. D., Farg, M. A., Turner, B. J., Tomas, D., Lysaght, J. A., Nunan, J., Rembach, A., Nagley, P., Beart, P. M., Cheema, S. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603393200 · Cited by 289
Retracted
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citation
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Bénichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,995
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,625

Show all 202 references

Research works printed but not linked: 2

Fitzmaurice, P. S. et al. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19, 797–798 (1996).
Highley, J. R. et al. TARDBP mutations, amyotrophic lateral sclerosis and alternative splicing in human fibroblasts. Brain Pathol. 20 (Suppl. 1), 32 (2010).

Sorted by citations

Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Amyotrophic lateral sclerosis
Hardiman, O. M., Al‐Chalabi, A., Chiò, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.71 · Cited by 2,262
Self-citation
Molecular mechanisms of cell death in neurological diseases
Moujalled, D., Strasser, A., & Liddell, J. R. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00814-y · Cited by 749
A comprehensive review of amyotrophic lateral sclerosis
Zarei, S., Carr, K., Reiley, L. E., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A. R. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.169561 · Cited by 775
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 683
ER–mitochondria associations are regulated by the VAPB–PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43
Stoica, R., Vos, K. J. D., Paillusson, S., Mueller, S., Sancho, R. M., Lau, K., Vizcay‐Barrena, G., Lin, W.-L., Xu, Y.-F., Lewis, J. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4996 · Cited by 652
Applications of machine learning to diagnosis and treatment of neurodegenerative diseases
Myszczynska, M. A., Ojamies, P. N., Lacoste, A. M. B., Neil, D., Saffari, A., Mead, R., Hautbergue, G. M., Holbrook, J. D., & Ferraiuolo, L. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0377-8 · Cited by 595
Self-citation
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
PARALS Registry, van Rheenen, W., SLALOM Group, SLAP Registry, NNIPPS Study Group, Shatunov, A., Dekker, A. M., McLaughlin, R. L., Diekstra, F. P., Pulit, S. L., et al. (2016) · Nature Genetics · doi:10.1038/ng.3622 · Cited by 577
Self-citation
The role of mitochondria in amyotrophic lateral sclerosis
Smith, E. F., Shaw, P. J., & Vos, K. J. D. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.06.052 · Cited by 579
Self-citation
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
Mead, R. J., Shan, N., Reiser, H. J., Marshall, F., & Shaw, P. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00612-2 · Cited by 505
Self-citation
C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking
Farg, M. A., Sundaramoorthy, V., Sultana, J. M., Yang, S., Atkinson, R. A. K., Levina, V., Halloran, M. A., Gleeson, P. A., Blair, I. P., Soo, K. Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu068 · Cited by 478
“We also recently demonstrated that mutant SOD1 induces dysfunction in the trafficking between the ER and Golgi compartments, another trafficking process regulated by Rab1 (44).”
BackgroundInfluential
There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D. H. W., Mueller, S., Miller, T., & Miller, C. C. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.008 · Cited by 439
Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis
Winkler, E. A., Sengillo, J. D., Sullivan, J. S., Henkel, J. S., Appel, S. H., & Zlokovic, B. V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1039-8 · Cited by 354
Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS
Meyer, K., Ferraiuolo, L., Miranda, C. J., Likhite, S., McElroy, S., Renusch, S., Ditsworth, D., Lagier-Tourenne, C., Smith, R. A., Ravits, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314085111 · Cited by 361
Self-citation
Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72
Cooper‐Knock, J., Hewitt, C., Highley, J. R., Brockington, A., Milano, A., Man, S., Martindale, J. E., Hartley, J. A., Walsh, T., Gelsthorpe, C., et al. (2012) · Brain · doi:10.1093/brain/awr365 · Cited by 342
Self-citation
The UPR ER : Sensor and Coordinator of Organismal Homeostasis
Frakes, A. E., & Dillin, A. G. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.031 · Cited by 302
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 294
Inhibition of Amyloid Formation
Härd, T., & Lendel, C. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.062 · Cited by 277
Interaction of Mitochondria with the Endoplasmic Reticulum and Plasma Membrane in Calcium Homeostasis, Lipid Trafficking and Mitochondrial Structure
Szymański, J., Janikiewicz, J., Michalska, B., Patalas‐Krawczyk, P., Perrone, M., Ziółkowski, W., Duszyński, J., Pinton, P., Dobrzyń, A., & Wieckowski, M. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071576 · Cited by 280
ALS/FTD‐associated FUS activates GSK‐3β to disrupt the VAPB–PTPIP51 interaction and ER–mitochondria associations
Stoica, R., Paillusson, S., Gómez‐Suaga, P., Mitchell, J. C., Lau, D. H. W., Gray, E. H., Sancho, R. M., Vizcay‐Barrena, G., Vos, K. J. D., Shaw, C. E., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541726 · Cited by 269
Effect of nutrition on neurodegenerative diseases. A systematic review
Bianchi, V. E., Herrera, P. F., & Rizzi, L. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1681088 · Cited by 268
Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?
Vos, K. J. D., & Hafezparast, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.004 · Cited by 238
The Role of Sex and Sex Hormones in Neurodegenerative Diseases
Vegeto, E., Villa, A. M., Torre, S. D., Crippa, V., Rusmini, P., Cristofani, R., Galbiati, M., Maggi, A. C., & Poletti, A. (2019) · Endocrine Reviews · doi:10.1210/endrev/bnz005 · Cited by 240
Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28
Zürcher, N. R., Loggia, M. L., Lawson, R., Chonde, D. B., Izquierdo-Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., Cudkowicz, M. E., et al. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.01.009 · Cited by 226
“This is an open access article under but there are no available treatments that prevent or stop disease progression and current animal models have not yet successfully predicted treatment response in people (Atassi et al., 2012; Ferraiuolo et al., 2011).”
BackgroundMethodInfluential
Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies
Vucic, S., Rothstein, J. D., & Kiernan, M. C. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.05.006 · Cited by 233
Gene expression profiling in human neurodegenerative disease
Cooper‐Knock, J., Kirby, J., Ferraiuolo, L., Heath, P. R., Rattray, M., & Shaw, P. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.156 · Cited by 229
Self-citation
Resveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice
Mancuso, R., del Valle, J., Mòdol, L., Martínez‐Muriana, A., Granado‐Serrano, A. B., Ramírez‐Núñez, O., Pallàs, M., Portero‐Otín, M., Osta, R., & Navarro, X. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0253-y · Cited by 212
Modelling amyotrophic lateral sclerosis: progress and possibilities
Damme, P. V., Robberecht, W., & Bosch, L. V. D. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029058 · Cited by 225
MicroRNAs and neurodegeneration: role and impact
Abe, M., & Bonini, N. M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.013 · Cited by 190
Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism
Ferraiuolo, L., Meyer, K., Sherwood, T. W., Vick, J. S., Likhite, S. B., Frakes, A., Miranda, C. J., Braun, L., Heath, P. R., Pineda, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607496113 · Cited by 205
Self-citation
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
DNA methylation, a hand behind neurodegenerative diseases
Lu, H., Liu, X., Yu-Lin, D. E. N. G., & Qing, H. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00085 · Cited by 181
Complete morphologies of basal forebrain cholinergic neurons in the mouse
Wu, H., Williams, J., & Nathans, J. (2014) · eLife · doi:10.7554/elife.02444 · Cited by 167
Protein aggregation and neurodegenerative diseases: From theory to therapy
Kumar, V., Sami, N., Kashav, T., Islam, A., Ahmad, F., & Hassan, M. I. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.054 · Cited by 183
Stress granules in neurodegeneration – lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma
Bentmann, E., Haass, C., & Dormann, D. (2013) · FEBS Journal · doi:10.1111/febs.12287 · Cited by 181
CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves
Martínez‐Muriana, A., Mancuso, R., Francos-Quijorna, I., Olmos‐Alonso, A., Osta, R., Perry, V. H., Navarro, X., Gómez‐Nicola, D., & López‐Vales, R. (2016) · Scientific Reports · doi:10.1038/srep25663 · Cited by 172
Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity
Birger, A., Ben‐Dor, I., Ottolenghi, M., Turetsky, T. T., Gil, Y., Sweetat, S., Perez, L., Belzer, V., Casden, N., Steiner, D., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.026 · Cited by 164
Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset
Rocha, M. C., Pousinha, P. A., Correia, A. M., Sebastião, A. M., & Ribeiro, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073846 · Cited by 165
The Unfolded Protein Response and the Role of Protein Disulfide Isomerase in Neurodegeneration
Perri, E. R., Thomas, C. J., Parakh, S., Spencer, D. M. S., & Atkin, J. D. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00080 · Cited by 170
Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis
Figueroa‐Romero, C., Hur, J., Bender, D. E., Delaney, C. E., Cataldo, M. D., Smith, A. L., Yung, R. L., Ruden, D. M., Callaghan, B. C., & Feldman, E. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052672 · Cited by 166
Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity
Brockington, A., Ning, K., Heath, P. R., Wood, E., Kirby, J., Fusi, N., Lawrence, N. D., Wharton, S. B., Ince, P. G., & Shaw, P. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1058-5 · Cited by 163
Self-citation
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
Fernández‐Ruíz, J., Moro, M. Á., & Martínez-Orgado, J. A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0381-7 · Cited by 156
ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN
Groen, E. J. N., Fumoto, K., Blokhuis, A. M., Engelen-Lee, J.-Y., Zhou, Y., van den Heuvel, D. M. A., Koppers, M., van Diggelen, F., van Heest, J., Demmers, J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt222 · Cited by 153
Self-citation
Molecular and Cellular Mechanisms Affected in ALS
Gall, L. L., Anakor, E., Connolly, O., Vijayakumar, U. G., Duddy, W. J., & Duguez, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030101 · Cited by 152
Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)
Waller, R., Goodall, G., Milo, M., Cooper‐Knock, J., Costa, M. D., Hobson, E., Kazoka, M., Wollff, H., Heath, P. R., Shaw, P. J., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.027 · Cited by 148
Self-citation
Retroviruses and amyotrophic lateral sclerosis
Alfahad, T. B., & Nath, A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.05.006 · Cited by 144
SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits
Hautbergue, G. M., Castelli, L. M., Ferraiuolo, L., Sánchez-Martínez, Á., Cooper‐Knock, J., Higginbottom, A., Lin, Y.-H., Bauer, C. S., Dodd, J. E., Myszczynska, M. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms16063 · Cited by 140
Self-citation
TDP-43/FUS in motor neuron disease: Complexity and challenges
Guerrero, E. N., Wang, H., Mitra, J., Hegde, P. M., Stowell, S. E., Liachko, N. F., Kraemer, B. C., Garruto, R. M., Rao, K. S. J., & Hegde, M. L. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.09.004 · Cited by 146
Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria
Mórotz, G. M., Vos, K. J. D., Vagnoni, A., Ackerley, S., Shaw, C. E., & Miller, C. C. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds011 · Cited by 139
Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis
Graffmo, K. S., Forsberg, K., Bergh, J., Birve, A., Zetterström, P., Andersen, P. M., Marklund, S. L., & Brännström, T. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds399 · Cited by 145
Fused in sarcoma (FUS): An oncogene goes awry in neurodegeneration
Dormann, D., & Haass, C. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.03.006 · Cited by 140
Dietary ω-3 Polyunsaturated Fatty Acid Intake and Risk for Amyotrophic Lateral Sclerosis
Fitzgerald, K. C., O’Reilly, É. J., Falcone, G. J., McCullough, M. L., Park, Y., Kolonel, L. N., & Ascherio, A. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1214 · Cited by 143
Mice deficient in Epg5 exhibit selective neuronal vulnerability to degeneration
Zhao, H., Zhao, Y. G., Wang, X., Xu, L., Miao, L., Feng, D., Chen, Q., Kovács, A. L., Fan, D., & Zhang, H. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201211014 · Cited by 132
Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS
D’Erchia, A. M., Gallo, A., Manzari, C., Raho, S., Horner, D. S., Chiara, M., Valletti, A., Aiello, I., Mastropasqua, F., Ciaccia, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10488-7 · Cited by 133
The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol
Kalmár, B., Lu, C., & Greensmith, L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.08.003 · Cited by 135
Synergistic Effects of GDNF and VEGF on Lifespan and Disease Progression in a Familial ALS Rat Model
Krakora, D., Mulcrone, P. L., Meyer, M., Lewis, C. M., Bernau, K., Gowing, G., Zimprich, C., Aebischer, P., Svendsen, C. N., & Suzuki, M. (2013) · Molecular Therapy · doi:10.1038/mt.2013.108 · Cited by 133
Neurotrophic Natural Products: Chemistry and Biology
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302268 · Cited by 124
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tefera, T. W., Steyn, F. J., Ngo, S. T., & Borges, K. (2021) · Cell & Bioscience · doi:10.1186/s13578-020-00511-2 · Cited by 122
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis
Tönges, L., Günther, R., Suhr, M., Jansen, J., Balck, A., Saal, K., Barski, E., Nientied, T., Götz, A. A., Koch, J., et al. (2014) · Glia · doi:10.1002/glia.22601 · Cited by 121
Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS
Armstrong, G. A. B., & Drapeau, P. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt278 · Cited by 131
ALS‐linked protein disulfide isomerase variants cause motor dysfunction
Woehlbier, U., Colombo, A., Saaranen, M. J., Pérez, V., Ojeda, J., Bustos, F. J., Andreu, C. I., Torres, M., Valenzuela, V., Medinas, D. B., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201592224 · Cited by 118
The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis
Tadić, V., Prell, T., Lautenschläger, J., & Großkreutz, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00147 · Cited by 115
Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic
Mancuso, R., & Navarro, X. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.004 · Cited by 125
Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress
Rojas, F., Cortés, N., Abarzúa, S., Dyrda, A., & van Zundert, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00024 · Cited by 120
Activation of mitochondrial transient receptor potential vanilloid 1 channel contributes to microglial migration
Miyake, T., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2015) · Glia · doi:10.1002/glia.22854 · Cited by 118
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model
Nizzardo, M., Simone, C., Rizzo, F., Ruggieri, M., Salani, S., Riboldi, G. M., Faravelli, I., Zanetta, C., Bresolin, N., Comi, G. P., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt425 · Cited by 113
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Aymerich, M. S., Aso, E., Abellanas, M. A., Tolón, R. M., Ramos, J. A., Ferrer, I., Romero, J., & Fernández‐Ruíz, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.016 · Cited by 113
Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis
Apolloni, S., Amadio, S., Montilli, C., Volonte, C., & D'Ambrosi, N. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt259 · Cited by 109
Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels
Möller, A., Bauer, C. S., Cohen, R. N., Webster, C. P., & Vos, K. J. D. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx348 · Cited by 109
Risk factors and emerging therapies in amyotrophic lateral sclerosis
Nowicka, N., Juranek, J., Juranek, J. K., & Wojtkiewicz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112616 · Cited by 106
The distinct genetic pattern of ALS in Turkey and novel mutations
Özoğuz, A., Uyan, Ö., Birdal, G., Tunca, C., Kartal, E., Lahut, S., Ömür, Ö., Ağım, Z. S., Eken, A. G., Şen, N.-E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.032 · Cited by 108
Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis
Allen, S. P., Hall, B., Castelli, L. M., Francis, L. I., Woof, R., Siskos, A., Kouloura, E., Gray, E., Thompson, A. G., Talbot, K., et al. (2019) · Brain · doi:10.1093/brain/awy353 · Cited by 102
Self-citation
Intermittent Hypoxia and Stem Cell Implants Preserve Breathing Capacity in a Rodent Model of Amyotrophic Lateral Sclerosis
Nichols, N. L., Gowing, G., Satriotomo, I., Nashold, L. J., Dale, E. A., Suzuki, M., Avalos, P., Mulcrone, P. L., McHugh, J., Svendsen, C. N., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-1072oc · Cited by 104
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Xiang, Y., Song, X., & Long, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03660-8 · Cited by 116
Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases
Novellino, F., Saccà, V., Donato, A., Zaffino, P., Spadea, M. F., Vismara, M. F. M., Arcidiacono, B., Malara, N., Presta, I., & Donato, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031115 · Cited by 107
Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
Webster, C. P., Smith, E. F., Shaw, P. J., & Vos, K. J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00123 · Cited by 109
Self-citation
Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons
Thiyagarajan, N., Ferguson, R., Subramanian, V., & Acharya, K. R. (2012) · Nature Communications · doi:10.1038/ncomms2126 · Cited by 99
The wobbler mouse, an ALS animal model
Moser, J., Bigini, P., & Schmitt‐John, T. (2013) · Molecular Genetics and Genomics · doi:10.1007/s00438-013-0741-0 · Cited by 108
Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling
Rojas, F., González, D., Cortés, N., Ampuero, E., Hernández, D. E., Fritz, E., Abarzúa, S., Martinez, A. N., Elorza, Á. A., Alvarez, A. R., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00203 · Cited by 97
Gene Therapy for ALS—A Perspective
Cappella, M., Ciotti, C., Cohen-Tannoudji, M., & Biferi, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184388 · Cited by 103
The cannabinoid system and microglia in health and disease
Duffy, S. S., Hayes, J. P., Fiore, N. T., & Moalem‐Taylor, G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108555 · Cited by 103
Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms
Markovinović, A., Cimbro, R., Ljutić, T., Križ, J., Rogelj, B., & Munitić, I. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.005 · Cited by 95
Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis
Nardo, G., Iennaco, R., Fusi, N., Heath, P. R., Marino, M., Trolese, M. C., Ferraiuolo, L., Lawrence, N. D., Shaw, P. J., & Bendotti, C. (2013) · Brain · doi:10.1093/brain/awt250 · Cited by 92
Self-citation
Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research
Su, X., Broach, J. R., Connor, J. R., Gerhard, G. S., & Simmons, Z. (2014) · Muscle & Nerve · doi:10.1002/mus.24198 · Cited by 94
Early interneuron dysfunction in ALS: Insights from a mutant sod1 zebrafish model
McGown, A., McDearmid, J. R., Panagiotaki, N., Tong, H., Mashhadi, S. A., Redhead, N., Lyon, A. N., Beattie, C. E., Shaw, P. J., & Ramesh, T. (2012) · Annals of Neurology · doi:10.1002/ana.23780 · Cited by 92
Self-citation
Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration
Gascon, E., & Gao, F.-B. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00048 · Cited by 69
SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system
Watanabe, S., Ageta‐Ishihara, N., Nagatsu, S., Takao, K., Komine, O., Endo, F., Miyakawa, T., Misawa, H., Takahashi, R., Kinoshita, M., et al. (2014) · Molecular Brain · doi:10.1186/s13041-014-0062-1 · Cited by 90
C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis
Allen, S. P., Hall, B., Woof, R., Francis, L. I., Gatto, N., Shaw, A. C., Myszczynska, M. A., Hemingway, J., Coldicott, I., Willcock, A., et al. (2019) · Brain · doi:10.1093/brain/awz302 · Cited by 89
Self-citation
Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases
Babazadeh, A., Vahed, F. M., & Jafari, S. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.015 · Cited by 90
Neurodegeneration in C. elegans models of ALS requires TIR-1/Sarm1 immune pathway activation in neurons
Vérièpe, J., Fossouo, L., & Parker, J. A. (2015) · Nature Communications · doi:10.1038/ncomms8319 · Cited by 86
The multifaceted role of glial cells in amyotrophic lateral sclerosis
Valori, C. F., Brambilla, L., Martorana, F., & Rossi, D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1429-7 · Cited by 88
Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis
Allen, S. P., Rajan, S. S., Duffy, L., Mortiboys, H., Higginbottom, A., Grierson, A. J., & Shaw, P. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.025 · Cited by 90
Self-citation
Mitochondrial Dysfunction in Neurodegenerative Diseases
Yang, H. (2025) · Cells · doi:10.3390/cells14040276 · Cited by 95
Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities
Tokuda, E., Okawa, E., Watanabe, S., Ono, S.-I., & Marklund, S. L. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.001 · Cited by 83
Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis
Liu, K. X., Edwards, B., Lee, S., Finelli, M. J., Davies, B., Davies, K. E., & Oliver, P. L. (2015) · Brain · doi:10.1093/brain/awv039 · Cited by 84
Probing impaired neurogenesis in human brain organoids exposed to alcohol
Zhu, Y., Wang, L., Yin, F., Yu, Y., Wang, Y., Shepard, M. J., Zhuang, Z., & Qin, J. (2017) · Integrative Biology · doi:10.1039/c7ib00105c · Cited by 87
Proteostasis impairment in ALS
Ruegsegger, C., & Saxena, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.032 · Cited by 88
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD 1G93A Transgenic Mice and Evaluation of a Sativex®‐like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
Moreno‐Martet, M., Espejo‐Porras, F., Fernández‐Ruíz, J., & de Lago, E. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12262 · Cited by 83
Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice
Chen, L., Na, R., McLane, K. D., Thompson, C. S., Gao, J., Wang, X., & Ran, Q. (2021) · Scientific Reports · doi:10.1038/s41598-021-92369-8 · Cited by 84

Authors: Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J.
Affiliations: University of Sheffield (GB)
University of Würzburg (DE)
Corresponding author: Shaw, Pamela J.
ORCID: Ferraiuolo, Laura
Kirby, Janine
Grierson, Andrew J.
Sendtner, Michael
Shaw, Pamela J.
Venue: Nature Reviews Neurology
Publisher: Springer Science and Business Media LLC
Published: 2011-11
Volume: 7
Issue: 11
Pages: 616-630
ISSN: 1759-4758 (ISSN-L)
1759-4766
DOI: 10.1038/nrneurol.2011.152
OpenAlex: W2025413109
Cited by: 615
References: 202
Citations by year: 2026: 12 · 2025: 24 · 2024: 34 · 2023: 25 · 2022: 27 · 2021: 54 · 2020: 34 · 2019: 37 · 2018: 33 · 2017: 42 · 2016: 58 · 2015: 63 · 2014: 63 · 2013: 64 · 2012: 45
FWCI: 6.83
Type: journal article
Language: en
Open access: green
zenodo.org
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Nature Reviews Neurology (publishedVersion)
PubMed (publishedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Funders: Wellcome Trust
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: amyotrophic lateral sclerosis, motor neuron injury, motor neuron degeneration, oxidative stress, mitochondrial dysfunction, excitotoxicity, superoxide dismutase 1, TDP-43, sporadic ALS, familial ALS, therapeutic target
MeSH terms: Amyotrophic Lateral Sclerosis, Humans, Motor Neurons, Nerve Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks